Literature DB >> 32127399

An RNA aptamer with potent affinity for a toxic dimer of amyloid β42 has potential utility for histochemical studies of Alzheimer's disease.

Kazuma Murakami1, Yayoi Obata2, Asa Sekikawa2, Haruka Ueda2, Naotaka Izuo3, Tatsuya Awano4, Keiji Takabe4, Takahiko Shimizu3, Kazuhiro Irie5.   

Abstract

Oligomers of β-amyloid 42 (Aβ42), rather than fibrils, drive the pathogenesis of Alzheimer's disease (AD). In particular, toxic oligomeric species called protofibrils (PFs) have attracted significant attention. Herein, we report RNA aptamers with higher affinity toward PFs derived from a toxic Aβ42 dimer than toward fibrils produced from WT Aβ42 or from a toxic, conformationally constrained Aβ42 variant, E22P-Aβ42. We obtained these RNA aptamers by using the preincubated dimer model of E22P-Aβ42, which dimerized via a linker located at Val-40, as the target of in vitro selection. This dimer formed PFs during incubation. Several physicochemical characteristics of an identified aptamer, E22P-AbD43, suggested that preferential affinity of this aptamer toward PFs is due to its higher affinity for the toxic dimer unit (KD = 20 ± 6.0 nm) of Aβ42 than for less-toxic Aβ40 aggregates. Comparison of CD data from the full-length and random regions of E22P-AbD43 suggested that the preferential binding of E22P-AbD43 toward the dimer might be related to the formation of a G-quadruplex structure. E22P-AbD43 significantly inhibited the nucleation phase of the dimer and its associated neurotoxicity in SH-SY5Y human neuroblastoma cells. Of note, E22P-AbD43 also significantly protected against the neurotoxicity of WT Aβ42 and E22P-Aβ42. Furthermore, in an AD mouse model, E22P-AbD43 preferentially recognized diffuse aggregates, which likely originated from PFs or higher-order oligomers with curvilinear structures, compared with senile plaques formed from fibrils. We conclude that the E22P-AbD43 aptamer is a promising research and diagnostic tool for further studies of AD etiology.
© 2020 Murakami et al.

Entities:  

Keywords:  Alzheimer disease; G-quadruplex; RNA; aggregation; amyloid-beta (AB); aptamer; circular dichroism (CD); immunohistochemistry; oligomer; transgenic mice

Mesh:

Substances:

Year:  2020        PMID: 32127399      PMCID: PMC7152766          DOI: 10.1074/jbc.RA119.010955

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease.

Authors:  Kazuma Murakami; Kazuhiro Irie; Akira Morimoto; Hajime Ohigashi; Mayumi Shindo; Masaya Nagao; Takahiko Shimizu; Takuji Shirasawa
Journal:  J Biol Chem       Date:  2003-08-27       Impact factor: 5.157

Review 2.  Amyloid beta-protein assembly and Alzheimer disease.

Authors:  Robin Roychaudhuri; Mingfeng Yang; Minako M Hoshi; David B Teplow
Journal:  J Biol Chem       Date:  2008-10-09       Impact factor: 5.157

3.  Observation of metastable Abeta amyloid protofibrils by atomic force microscopy.

Authors:  J D Harper; S S Wong; C M Lieber; P T Lansbury
Journal:  Chem Biol       Date:  1997-02

4.  Abeta N-terminal-end specific antibody reduced beta-amyloid in Alzheimer-model mice.

Authors:  Yuko Horikoshi; Takashi Mori; Masahiro Maeda; Noriaki Kinoshita; Kumiko Sato; Haruyasu Yamaguchi
Journal:  Biochem Biophys Res Commun       Date:  2004-12-10       Impact factor: 3.575

Review 5.  Aptamers as targeted therapeutics: current potential and challenges.

Authors:  Jiehua Zhou; John Rossi
Journal:  Nat Rev Drug Discov       Date:  2016-11-03       Impact factor: 84.694

6.  Analysis of protein-ligand interactions by fluorescence polarization.

Authors:  Ana M Rossi; Colin W Taylor
Journal:  Nat Protoc       Date:  2011-03-03       Impact factor: 13.491

7.  Presenilin-2 mutation causes early amyloid accumulation and memory impairment in a transgenic mouse model of Alzheimer's disease.

Authors:  Toshihiko Toda; Yoshihiro Noda; Genzo Ito; Masahiro Maeda; Takahiko Shimizu
Journal:  J Biomed Biotechnol       Date:  2010-12-29

8.  Human telomeric sequence forms a hybrid-type intramolecular G-quadruplex structure with mixed parallel/antiparallel strands in potassium solution.

Authors:  Attila Ambrus; Ding Chen; Jixun Dai; Tiffanie Bialis; Roger A Jones; Danzhou Yang
Journal:  Nucleic Acids Res       Date:  2006-05-19       Impact factor: 16.971

9.  RNA aptamers generated against oligomeric Abeta40 recognize common amyloid aptatopes with low specificity but high sensitivity.

Authors:  Farid Rahimi; Kazuma Murakami; Jamie L Summers; Chi-Hong B Chen; Gal Bitan
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

10.  Monoclonal antibody with conformational specificity for a toxic conformer of amyloid β42 and its application toward the Alzheimer's disease diagnosis.

Authors:  Kazuma Murakami; Maki Tokuda; Takashi Suzuki; Yumi Irie; Mizuho Hanaki; Naotaka Izuo; Yoko Monobe; Ken-Ichi Akagi; Ryotaro Ishii; Harutsugu Tatebe; Takahiko Tokuda; Masahiro Maeda; Toshiaki Kume; Takahiko Shimizu; Kazuhiro Irie
Journal:  Sci Rep       Date:  2016-07-04       Impact factor: 4.379

View more
  3 in total

1.  Glycated albumin precipitation using aptamer conjugated magnetic nanoparticles.

Authors:  R Fayazi; M Habibi-Rezaei; M Heiat; F Javadi-Zarnaghi; R A Taheri
Journal:  Sci Rep       Date:  2020-07-01       Impact factor: 4.379

Review 2.  Advances in aptamers against Aβ and applications in Aβ detection and regulation for Alzheimer's disease.

Authors:  Yan Zheng; Limin Zhang; Jinge Zhao; Lingyun Li; Minxuan Wang; Peifeng Gao; Qing Wang; Xiaoling Zhang; Weizhi Wang
Journal:  Theranostics       Date:  2022-01-31       Impact factor: 11.556

Review 3.  RNA-based therapeutics for neurological diseases.

Authors:  Karen Anthony
Journal:  RNA Biol       Date:  2021-12-31       Impact factor: 4.652

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.